A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Eisai Inc.
Sanofi
The First Affiliated Hospital of Zhengzhou University
Saint Petersburg State University, Russia
DHR Health Institute for Research and Development
University Health Network, Toronto
Khon Kaen University
Copenhagen University Hospital at Herlev
Yonsei University
National Institutes of Health Clinical Center (CC)